Skip to main content
Wave Life Sciences Ltd. logo

Wave Life Sciences Ltd. — Investor Relations & Filings

Ticker · WVE ISIN · USY953081053 US Manufacturing
Filings indexed 671 across all filing types
Latest filing 2026-05-18 Regulatory Filings
Country US United States of America
Listing US WVE

About Wave Life Sciences Ltd.

https://www.wavelifesciences.com/

Wave Life Sciences is a clinical-stage biotechnology company focused on developing RNA-based medicines to treat serious, genetically defined diseases. The company leverages its proprietary PRISM® platform, which utilizes a toolkit of RNA-targeting modalities and chemistry innovations to create stereopure nucleic acid therapies. Wave's objective is to deliver disease-modifying treatments for conditions with high unmet medical needs. Its development pipeline includes therapeutic candidates for both rare and common disorders, with programs targeting neurological conditions like Huntington's disease and Duchenne muscular dystrophy, as well as other diseases such as Alpha-1 antitrypsin deficiency and obesity.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2026-05-18 English
10-Q - Wave Life Sciences Ltd. (0001631574) (Filer)
Interim / Quarterly Report
2026-04-28 English
8-K - Wave Life Sciences Ltd. (0001631574) (Filer)
Regulatory Filings
2026-04-28 English
8-K - Wave Life Sciences Ltd. (0001631574) (Filer)
Regulatory Filings
2026-04-21 English
8-K - Wave Life Sciences Ltd. (0001631574) (Filer)
Regulatory Filings
2026-04-15 English
SCHEDULE 13D/A - Wave Life Sciences Ltd. (0001631574) (Subject)
Major Shareholding Notification
2026-03-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.